TABLE 1.
Characteristics of included patients
| Variable | Total (N = 93) |
|---|---|
| Age, median [IQR] | 67 [60–76] |
| Male, n (%) | 43 (46.2%) |
| Primary disease | |
| Pancreatic cancer | 68 (73.1%) |
| Duodenal / ampullary cancer | 10 (10.7%) |
| Cholangiocarcinoma | 4 (4.3%) |
| Others* | 11 (11.8%) |
| Oncological staging | |
| Resectable | 4 (4.3%) |
| Borderline resectable | 5 (5.4%) |
| Locally advanced | 29 (31.2%) |
| Metastatic | 53 (57%) |
| N.A. | 2 |
| Ascites | 18 (19.4%) |
| Peritoneal disease | 19 (20.4%) |
| Symptoms onset | |
| Biliary first | 60 (64.5%) |
| Concomitant | 24 (25.8%) |
| Gastric outlet obstruction first | 9 (9.7%) |
| Median interval between procedures, days [IQR] | 31 [5‐68] |
Abbreviation: N.A., not available.
*
Gallbladder cancer/neuroendocrine tumors/metastatic diseases.